|本期目录/Table of Contents|

[1]栗瑞斌,王倩,张雷杰,等.负载酪氨酸酶抑制肽的牛奶外泌体抑制酪氨酸酶活性及黑色素生成研究[J].天津医科大学学报,2022,28(04):348-352,371.
 LI Rui-bin,WANG Qian,ZHANG Lei-jie,et al.Inhibition of tyrosinase activity and melanin synthesis by milk exosomes loaded with tyrosinase inhibitory peptide[J].Journal of Tianjin Medical University,2022,28(04):348-352,371.
点击复制

负载酪氨酸酶抑制肽的牛奶外泌体抑制酪氨酸酶活性及黑色素生成研究(PDF)
分享到:

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
28卷
期数:
2022年04期
页码:
348-352,371
栏目:
外泌体专题
出版日期:
2022-07-20

文章信息/Info

Title:
Inhibition of tyrosinase activity and melanin synthesis by milk exosomes loaded with tyrosinase inhibitory peptide
文章编号:
1006-8147(2022)04-0348-06
作者:
栗瑞斌王倩张雷杰荆韧威尹海芳
(天津医科大学基础医学院细胞生物学系,天津 300070)
Author(s):
LI Rui-binWANG QianZHANG Lei-jieJING Ren-weiYIN Hai-fang
(Department of Cell Biology,School of Basic Medical Sciences,Tianjin Medical University,Tianjin 300070,China)
关键词:
黑色素瘤牛奶外泌体酪氨酸酶抑制肽靶向治疗
Keywords:
melanomamilk exosometyrosinase inhibitory peptidetargeted therapy
分类号:
R781.4
DOI:
-
文献标志码:
A
摘要:
目的:探讨酪氨酸酶抑制肽(YRS)功能化的牛奶外泌体(mEXOYRS),对酪氨酸酶活性及黑色素生成的抑制作用。方法:通过超速离心法获取牛奶外泌体(mEXO);利用外泌体特异锚定肽CP05将YRS修饰在mEXO表面,获得mEXOYRS,随后通过流式细胞仪分析YRS的负载效率;在黑色素瘤细胞B16-F10中,检测细胞对mEXOYRS的摄取效率以及YRS与酪氨酸酶的共定位效率,评估mEXOYRS对B16-F10黑色素瘤细胞酪氨酸酶活性的抑制效果及对黑色素合成的抑制作用;进一步将mEXOYRS均匀涂抹于Nude BALB/c小鼠黑色素瘤细胞B16-F10所成皮下瘤模型上,评估其在体内对黑色素合成的抑制作用;通过对C57BL/6小鼠表面皮肤涂抹mEXOYRS,评估其对小鼠毛囊的着色程度及小鼠皮肤的美白效果。结果:YRS通过外泌体特异锚定肽CP05高效负载至mEXO,并且不影响mEXO的形态结构及标志性蛋白的表达;在B16-F10黑色素瘤细胞摄取实验中,mEXO能够增强YRS与细胞内酪氨酸酶共定位的效率,在1周、2周及6周时均显著抑制细胞产生黑色素(F=56.117、48.954、560.006,均P<0.05);在Nude BALB/c小鼠黑色素皮下瘤模型中,与YRS组相比,mEXOYRS更好的抑制了黑色素的产生;在C57BL/6小鼠模型中,mEXOYRS降低了黑色素的产生,并显著降低了黑色素含量(F=173.083,P<0.05)及酪氨酸酶活性指标(F=34.156,P<0.05),取得了美白效果。结论:YRS修饰的mEXO可通过内体转运途径,靶向运输到酪氨酸酶处,降低酪氨酸酶活性,并有效抑制黑色素生成,提高YRS的美白效果。
Abstract:
Objective: To investigate the inhibitory effect of milk-derived exosomes functionalized with tyrosinase inhibitory peptide YRS (mEXOYRS) on tyrosinase activity and melanin synthesis. Methods:Milk exosomes(mEXO) were isolated and purified via ultracentrifugation. The YRS peptide was loaded on mEXO surface with exosomal anchor peptide CP05 to form mEXOYRS. The loading efficiency of YRS peptide was analyzed by flow cytometer. In B16-F10 melanoma cells,the uptake efficiency of mEXOYRS,co-localization of YRS peptide and tyrosinase were detected. The inhibitory effect of mEXOYRS on tyrosinase activity and melanin synthesis were evaluated in melanoma cells B16-F10. mEXOYRS was uniformly applied to subcutaneous melanoma model of Nude BALB/c melanoma cell B16-F10 to evaluate its inhibitory effect on melanin synthesis in vivo. mEXOYRS was applied to the skin of C57BL/6 mice to evaluate the whitening effect of mEXOYRS and the color degree of hair follicles. Results: The YRS peptide was efficiently loaded on mEXO via CP05 without altering mEXO morphological structure and exosomal biomarker expression. In B16-F10 melanoma cell uptake experiments,mEXO could improve the efficiency of YRS uptake,and enhance the efficiency of YRS co-localization with tyrosinase. At 1,2 and 6 weeks,melanin synthesis was significantly inhibited(F=56.117,48.954,560.006,all P<0.05). In the Nude BALB/c mouse model of melanoma subcutaneous tumor,mEXOYRS significantly inhibited melanin synthesis compared to YRS group. In C57BL/6 mouse models,mEXOYRS reduced melanin synthesis and significantly inhibited the amout of melanin(F=173.083,P<0.05) and tyrosinase activity(F=34.156,P<0.05). Conclusion: mEXOYRS can be transported to tyrosinase through endosomal transport pathway,reduce tyrosinase activity,resulting in reduction of melanin production and improvement of whitening effect of YRS in vivo.

参考文献/References:

[1] CORDERO RJB,CASADEVALL A. Melanin[J]. Curr Biol,2020,30(4):R142-R143.
[2] LAI X,WICHERS H J,SOLER-LOPEZ M,et al. Structure and function of human tyrosinase and tyrosinase-related proteins[J]. Chemistry,2018,24(1):47-55.
[3] WANG L,FENG Y,WANG J,et al. Arbutin ameliorates murine colitis by inhibiting JAK2 signaling pathway[J]. Front Pharmacol,2021,12:683818.
[4] MA C,ZHANG D,MA Q,et al. Arbutin inhibits inflammation and apoptosis by enhancing autophagy via SIRT1[J]. Adv Clin Exp Med,2021,30(5):535-544.
[5] ENGUITA F J,LEIT?魨O A L. Hydroquinone:environmental pollution,toxicity,and microbial answers[J]. Biomed Res Int,2013,2013:542168.
[6] MA W,LONG Y T. Quinone/hydroquinone-functionalized biointerfaces for biological applications from the macro- to nano-scale[J]. Chem Soc Rev,2014,43(1):30-41.
[7] BHATTARAI N,KORHONEN E,TOPPILA M,et al. Resvega alleviates hydroquinone-induced oxidative stress in ARPE-19 cells[J]. Int J Mol Sci,2020,21(6):11-19.
[8] MA C,HE N,ZHAO Y,et al. Antimicrobial mechanism of hydroquinone[J]. Appl Biochem Biotechnol,2019,189(4):1291-1303.
[9] SREENIVASAN C C,THOMAS M,KAUSHIK R S,et al. Influenza A in bovine species:a narrative literature review[J]. Viruses,2019,11(6):32-50.
[10] VALADI H,EKSTR?魻M K,BOSSIOS A,et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells[J]. Nat Cell Biol,2007,9(6):654-659.
[11] EKSTR?魻M K,VALADI H,SJ?魻STRAND M,et al. Characterization of mRNA and microRNA in human mast cell-derived exosomes and their transfer to other mast cells and blood CD34 progenitor cells[J]. J Extracell Vesicles,2012,1(5):20-35.
[12] YAMASHITA T,TAKAHASHI Y,TAKAKURA Y. Possibility of exosome-based therapeutics and challenges in production of exosomes eligible for therapeutic application[J]. Biol Pharm Bull,2018,41(6):835-842.
[13] WU D,CHEN J S,CHANG D C,et al. Mir-434-5p mediates skin whitening and lightening[J]. Clin Cosmet Investig Dermatol,2008,1:19-35.
[14] ZHONG J,XIA B,SHAN S,et al. High-quality milk exosomes as oral drug delivery system[J]. Biomaterials,2021,277:121126.
[15] GAO X,RAN N,DONG X,et al. Anchor peptide captures,targets,and loads exosomes of diverse origins for diagnostics and therapy[J]. Sci Transl Med,2018,10(444):386-395.
[16] SCHLESSINGER D I,ANORUO M,SCHLESSINGER J. Biochemistry,Melanin[A]. In:StatPearls.Treasure Island(FL):StatPearls Publishing Copyright ■ 2022,StatPearls Publishing LLC.,2022.
[17] MANN T,GERWAT W,BATZER J,et al. Inhibition of human tyrosinase requires molecular motifs distinctively different from mushroom tyrosinase[J]. J Invest Dermatol,2018,138(7):1601-1608.
[18] HARIRI R,SAEEDI M,AKBARZADEH T. Naturally occurring and synthetic peptides:Efficient tyrosinase inhibitors[J]. J Pept Sci,2021,27(7):e3329.
[19] BAE I S,KIM S H. Milk exosome-derived microRNA-2478 suppresses melanogenesis through the Akt-GSK3β pathway[J]. Cells,2021,10(11):638-651.
[20] 黄硕,刘风.栀子叶乙醇提取物对B16黑色素瘤细胞黑色素生成及酪氨酸酶活性的影响[J].中国当代医药,2020,27(36):5-17.
[21] SEBARATNAM D F,VENUGOPAL S S,FREW J W,et al. Diffuse melanosis cu-tis:a systematic review of the literature[J]. J Am Acad Dermatol,2013,68(3):482-488.

相似文献/References:

[1]田原,马跃美,刘艳荣,等.炎症因子IL-23对黑色素瘤B16F10细胞增殖和侵袭能力的影响[J].天津医科大学学报,2014,20(01):8.
 TIAN Yuan,MA Yue-mei,LIU Yan-rong,et al.Effects of IL-23 on proliferation and invasion of B16 melanoma cells[J].Journal of Tianjin Medical University,2014,20(04):8.
[2]文明明,马跃美,赵秀兰,等.炎症因子IL-23 对黑色素瘤细胞增殖侵袭及双向分化的影响[J].天津医科大学学报,2017,23(04):295.
 WEN Ming-ming,MA Yue-mei,ZHAO Xiu-lan,et al.Effects of IL-23 on the herin proliferation,invasion and bi-differentiation? of melanoma cells[J].Journal of Tianjin Medical University,2017,23(04):295.
[3]董玥湘,刘岩,靳小石,等.应用CRISPR/Cas9技术敲除SLC5A8基因对黑色素瘤的影响[J].天津医科大学学报,2024,30(02):128.[doi:10.20135/j.issn.1006-8147.2024.02.0128]
 DONG Yuexiang,LIU Yan,JIN Xiaoshi,et al.Effect of knockdown of SLC5A8 gene on melanoma by applying CRISPR/Cas9 technology[J].Journal of Tianjin Medical University,2024,30(04):128.[doi:10.20135/j.issn.1006-8147.2024.02.0128]

备注/Memo

备注/Memo:
基金项目 天津市自然科学基金青年项目(20JCQNJC00580)
作者简介:栗瑞斌(1997-),男,硕士在读,研究方向:牛奶外泌体相关研究;通信作者:尹海芳,E-mail:haifangyin@tmu.edu.cn;荆韧威,E-mail:jingrenwei@tmu.edu.cn。
更新日期/Last Update: 2022-07-20